NEW YORK (GenomeWeb) — DNA testing firm PathogenDx announced today that it has closed a $3.4 million convertible note round.

The round was co-led by Altitude Investment Management and the Panther Opportunity Fund, with participation from CanopyVentures, Tendaji Investments, PB Venture Group, Salveo Capital, Halley Valley Venture, FlatIron Group, and Spearflower VC. Specific terms of the round were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.